Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue:
Drug safety advice
-
Statins: interactions, and updated advice for atorvastatin
-
Methylthioninium chloride (methylene blue): CNS toxicity with serotonergic drugs
-
Desmomelt (desmopressin): call for Yellow Card reporting
-
Bivalirudin: risks associated with incorrect dose
Yellow Card scheme update
-
What happens to Yellow Card data?
Hot topic
-
Long-acting β2 agonists for asthma: review
Stop Press
-
Carisoprodol: recommendation to suspend Marketing Authorisations
-
Paraffin-based skin treatments: risk of fire hazard
-
Oral anticancer medicines: risk of incorrect dosing
Other information from the MHRA
-
Patient Information Leaflet of the month
Drug Safety Update: Volume 1, Issue 6, January 2008 
